Tactics for type II diabetes

Endocrinology and Metabolism Clinics of North America

Volumn 26, Issue 3, 1997, Pages 659-677

  Riddle, M C ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACARBOSE; ANTIDIABETIC AGENT; GLIBENCLAMIDE; GLIMEPIRIDE; GLIPIZIDE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; ISOPHANE INSULIN; METFORMIN; SULFONYLUREA DERIVATIVE; TROGLITAZONE;

CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DIET THERAPY; GASTROINTESTINAL TOXICITY; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; LIFESTYLE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW; SCREENING; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030798378     PISSN: 08898529     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8529(05)70273-5     Document Type: Article

References (76)

1. American Diabetes Association Standards of medical care for patients with diabetes mellitus Diabetes Care 20 suppl 1 1997 S5 S13
2. American Diabetes Association Screening for diabetes Diabetes Care 20 suppl 1 1997 S22 S23
3. P. Arner T. Pollare Lithell Different etiologies of type II diabetes in obese and nonobese subjects Diabetologia 34 1991 483 487
4. A.H. Barnett C. Eff R.D.G. Leslie Diabetes in identical twins Diabetologia 20 1981 87 93
5. M. Bayraktar D.H. Van Thiel N. Adalar A comparison of acarbose versus metformin as adjuvant therapy in sulfonylurea-treated NIDDM patients Diabetes Care 19 1996 252 254
6. M. Berelowitz C. Fischette W. Cefalu Comparative efficacy of a once-daily controlled-release formulation of glipizide and immediate-release glipizide in patients with NIDDM Diabetes Care 17 1994 1460 1464
7. M. Bojestig H.J. Arnqvist G. Hermansson Declining incidence of nephropathy in insulin-dependent diabetes mellitus N Engl J Med 330 1994 15 18
8. 1c testing in a community setting Diabetes Care 19 1996 764 767
9. J.-L. Chiasson R.G. Josse J.A. Hunt The efficacy of acarbose in the treatment of patients with non–insulin-dependent diabetes mellitus Ann Intern Med 121 1994 928 934
10. C.C. Cowie M.I. Harris M.S. Eberhardt Frequency and determinants of screening for diabetes in the US Diabetes Care 17 1994 1158 1163
11. C.C. Cowie M.S. Eberhardt Sociodemographic characteristics of persons with diabetes Diabetes in America ed 2 1995 National Institutes of Health Bethesda, MD 85 116
12. C.C. Cowie M.I. Harris Physical and metabolic characteristics of persons with diabetes Diabetes in America ed 2 1995 National Institutes of Health Bethesda, MD 117 164
13. DCCT Research Group The effect of intensive treatment of diabetes on the development and progression of long-term complications of insulin-dependent diabetes mellitus N Engl J Med 329 1993 977 986
14. DCCT Research Group The absence of a glycemic threshold for the development of long-term complications: The perspective of the Diabetes Control and Complications Trial Diabetes 45 1996 1289 1298
15. R.A. DeFronzo The triumvirate: β-cell, muscle, liver. A collusion responsible for NIDDM Diabetes 37 1987 667 687
16. L.-F. Eriksson F. Lindgarde Prevention of type 2 (non–insulin-dependent) diabetes mellitus by diet and physical exercise. The 6-year Malmo feasibility study Diabetologia 34 1991 891 898
17. P. Froguel H. Zouli N. Vionett Familial hyperglycemia due to mutations in glucokinase: Definition of a subtype of diabetes N Engl J Med 328 1993 697 702
18. W.Y. Fujimoto A national multicenter study to learn whether type II diabetes can be prevented: The Diabetes Prevention Program Clinical Diabetes Jan/Feb 1997 13 15
19. R.B. Goldberg S.M. Holvey J. Schneider A dose-response study of glimepiride in patients with NIDDM who have previously received sulfonylurea agents Diabetes Care 19 1996 849 856
20. S. Greenfield W. Rogers M. Mangotich Outcomes of patients with hypertension and non–insulin-dependent diabetes mellitus treated by different systems and specialists J Am Med Assoc 274 1995 1436 1444
21. S.M. Genuth Plasma insulin and glucose profiles in normal, obese, and diabetic persons Ann Intern Med 79 1973 812 822
22. S. Genuth Management of the adult onset diabetic with sulfonylurea drug failure Endocrinol Metab Clin North Am 21 1992 351 370
23. D.R. Hadden A.L.T. Blair E.A. Wilson Natural history of diabetes presenting age 40–69 years: A prospective study of the influence of intensive dietary therapy Q J Med 59 1986 579 598
24. R.L. Hanson R.G. Nelson D.R. McCance Comparison of screening tests for non–insulin-dependent diabetes mellitus Arch Intern Med 153 1993 2133 2140
25. M.I. Harris R. Klein T.A. Welborn Onset of NIDDM occurs at least 4–7 years before clinical diagnosis Diabetes Care 15 1992 815 819
26. M.I. Harris Undiagnosed NIDDM: Clinical and public health issues Diabetes Care 16 1993 642 652
27. R. Hellman J. Regan H. Rosen Effect of intensive treatment of diabetes on the risk of death or renal failure in NIDDM and IDDM Diabetes Care 20 1997 258 264
28. R.R. Henry B. Gumbiner T. Ditzler Intensive conventional insulin therapy for type 2 diabetes: Metabolic effects during a 6-month outpatient trial Diabetes Care 16 1993 21 31
29. L.S. Hermann B. Schersten P.-O. Bitzen Therapeutic comparison of metformin and sulfonylurea, alone in various combinations Diabetes Care 17 1994 1100 1109
30. R.G. Hiss S. Greenfield Changes in the US health care system that would facilitate improved care for non–insulin-dependent diabetes mellitus Ann Intern Med 124 1996 180 183
31. C. Johnston W.K. Ward J.C. Beard Islet function and insulin sensitivity in the nondiabetic offspring of conjugal type 2 diabetic patients Diabet Med 7 1990 119 125
32. C.R. Kahn Insulin action, diabetogenes, and the cause of type II diabetes Diabetes 43 1994 1066 1084
33. C.R. Kahn D. Vicent A. Doria Genetics of non–insulin-dependent (type 2) diabetes mellitus Annu Rev Med 47 1996 509 531
34. S.L. Kjos R.K. Peters A. Xiang Predicting future diabetes in Latino women with gestational diabetes: Utility of early postpartum glucose tolerance testing Diabetes 44 1995 586 591
35. R. Klein Hyperglycemia and microvascular and macrovascular disease in diabetes Diabetes Care 18 1995 258 268
36. R. Klein B.E.K. Klein S.E. Moss Relation of glycemic control to diabetic microvascular complications in diabetes mellitus Ann Intern Med 124 1996 90 96
37. G.T.C. Ko J.C.N. Chan E. Lau Fasting plasma glucose as a screening test for diabetes and its relationship with cardiovascular risk factors in Hong Kong Chinese Diabetes Care 20 1997 170 172
38. A.S. Krolewski J.H. Warram M.B.S. Freire Epidemiology of late diabetic complications: A basis for the development and evaluation of preventive programs Endocrinol Metab Clin North Am 25 1996 217 242
39. Y.T. Kruszymka J.M. Olefsky Cellular and molecular mechanisms of non–insulin-dependent diabetes mellitus J Invest Med 44 1996 413 428
40. S. Lillioja D.M. Mott M. Spraul Insulin resistance and insulin secretory dysfunction as precursors of non–insulin-dependent diabetes mellitus: Prospective studies of Pima Indians N Engl J Med 329 1993 1888 1892
41. R.S. Mazze D.D. Etzwiler E. Strock Staged diabetes management: Toward an integrated model of diabetes care Diabetes Care 17 suppl 1 1994 56 66
42. D.R. McCance R.L. Hanson M.-A. Charles Comparison of tests for glycated hemoglobin and fasting and 2 hour plasma glucose concentrations as diagnostic methods for diabetes BMJ 308 1994 1323 1328
43. D.R. McCance R.L. Hanson M.-A. Charles Which test for diagnosing diabetes? Diabetes Care 18 1995 1042 1044
44. D.K. McCulloch R.E. Glasgow S.E. Hampson A systematic approach to diabetes management in the post-DCCT era Diabetes Care 17 1994 756 769
45. G.S. Meneilly T. Elliott D. Tessier NIDDM in the elderly Diabetes Care 19 1996 1320 1325
46. B.E. Metzger N.H. Cho S.M. Roston Prepregnancy weight and antepartum insulin secretion predict glucose tolerance 5 years after gestational diabetes mellitus Diabetes Care 12 1993 1598 1605
47. A. Mitrakou D. Kelley M. Mokan Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance N Engl J Med 326 1992 22 29
48. M. Modan M.I. Harris Fasting plasma glucose in screening for NIDDM in the US and Israel Diabetes Care 17 1994 436 449
49. K.M.V. Narayan R.L. Hanson D.J. Pettitt A two step strategy for identification of high risk subjects for a clinical trial of prevention of NIDDM Diabetes Care 19 1996 972 978
50. D.M. Nathan Inferences and implications: Do results from the Diabetes Control and Complications Trial apply in NIDDM? Diabetes Care 18 1995 251 257
51. D.M. Nathan The pathophysiology of diabetic complications: How much does the glucose hypothesis explain? Ann Intern Med 124 1996 86 89
52. Y. Ohkubo H. Kishikawa E. Araki Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non–insulin-dependent diabetes mellitus: A randomized prospective 6-year study Diabetes Res Clin Pract 28 1995 103 117
53. J.B. O'Sullivan Diabetes mellitus after GDM Diabetes 29 suppl 2 1991 131 135
54. S. Park E. Barrett-Connor D.L. Wingard GHb is a better predictor of cardiovascular disease than fasting or postchallenge plasma glucose in women without diabetes: The Rancho Bernardo Study Diabetes Care 19 1996 450 456
55. A.L. Peters M.B. Davidson D.L. Schriger A clinical approach for the diagnosis of diabetes mellitus: An analysis using glycosylated hemoglobin levels JAMA 276 1996 1246 1252
56. J. Pirart Diabetes mellitus and its degenerative complications: A prospective study of 4400 patients observed between 1947 and 1973 Diabetes Care 1 1978 168 188 252–263
57. K.S. Polonsky J. Sturis G. Bell Non–insulin-dependent diabetes mellitus—a genetically programmed failure of the beta cell to compensate for insulin resistance N Engl J Med 334 1996 777 783
58. K.E. Quickel Diabetes in a managed care system Ann Intern Med 124 1996 160 163
59. G.M. Reaven C.K. Lardinois M.S. Greenfield Effect of acarbose on carbohydrate and lipid metabolism in NIDDM patients poorly controlled by sulfonylureas Diabetes Care 13 suppl 3 1990 32 36
60. M.C. Riddle J.S. Hart D.J. Bouma Efficacy of bedtime NPH insulin with daytime sulfonylurea for a subpopulation of type II diabetes mellitus Diabetes Care 12 1989 623 629
61. M.C. Riddle J. Hart P. Bingham Combined therapy for obese type 2 diabetes: Suppertime mixed insulin with daytime sulfonylurea Am J Med Sci 303 1992 151 156
62. M.C. Riddle Combined therapy with a sulfonylurea plus evening insulin: Safe, reliable, and becoming routine Horm Metab Res 28 1996 430 433
63. M.C. Riddle D.M. Karl Commentary on: Outcomes of patients with hypertension and non–insulin-dependent diabetes mellitus treated by different systems and specialities: Results from the Medical Outcomes Study Diabetes Spectrum 9 1996 176 178
64. J.U. Rosenstock E. Samols D.B. Muchmore Glimepiride, a new once daily sulfonylurea Diabetes Care 19 1996 1194 1199
65. R.J. Rubin W.M. Altman D.N. Mendelson Health care expenditures of people with diabetes, 1992 J Clin Endocrinol Metab 78 1994 809A 809F
66. E.A. Ryan S. Imes D. Liu Defects of insulin secretion and action in women with a history of gestational diabetes Diabetes 44 1995 506 512
67. M.L. Shank S. DelPrato R.A. DeFronzo Bedtime insulin/daytime glipizide: Effective therapy for sulfonylurea failures in NIDDM Diabetes 44 1995 165 172
68. J.S. Skyler Diabetic complications: The importance of glucose control Endocrinol Metab Clin North Am 25 1996 243 254
69. M. Stumvoll N. Nurjhan G. Perriello Metabolic effects of metformin in non–insulin-dependent diabetes mellitus N Engl J Med 333 1995 550 554
70. P.A. Torjesen K.I. Birkeland S.A. Anderssen Lifestyle changes may reverse development of the insulin resistance syndrome: The Oslo Diet and Exercise Study. A randomized trial Diabetes Care 20 1997 26 31
71. UK Prospective Diabetes Study 7 Response of fasting plasma glucose to diet therapy in newly presenting type II diabetic patients Metabolism 39 1990 905 912
72. UK Prospective Diabetes Study 16 Overview of 6 years' therapy of type II diabetes: A progressive disease Diabetes 44 1995 1249 1258
73. A. Vaag J.E. Henricksen S. Madsbad Insulin secretion, insulin action, and hepatic glucose production in identical twins discordant for non–insulin-dependent diabetes mellitus J Clin Invest 95 1995 690 698
74. W.K. Ward C.L.W. Johnston J.C. Beard Insulin and impaired insulin secretion in subjects with a history of gestational diabetes mellitus Diabetes 34 1985 861 869
75. J.E. Ware M.S. Bayliss W.H. Rogers Differences in 4-year health outcomes for elderly and poor, chronically ill patients treated in HMO and fee-for-service systems: Results from the Medical Outcomes Study J Am Med Assoc 276 1996 1039 1047
76. M. Weinberger E.Z. Oddone W.G. Henderson Does increased access to primary care reduce hospital readmissions? N Engl J Med 334 1996 1441 1447